Hualan Biological Engineering Inc. (SHE:002007)
China
· Delayed Price · Currency is CNY 15.46
+0.05 (0.32%)
At close: Dec 5, 2025
SHE:002007 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 4,254 | 4,366 | 5,333 | 4,503 | 4,426 | 5,016 | Upgrade
|
| Other Revenue | 13.58 | 13.58 | 8.9 | 13.67 | 10.31 | 7.09 | Upgrade
|
| Revenue | 4,267 | 4,379 | 5,342 | 4,517 | 4,436 | 5,023 | Upgrade
|
| Revenue Growth (YoY) | -13.26% | -18.02% | 18.26% | 1.82% | -11.69% | 35.76% | Upgrade
|
| Cost of Revenue | 1,864 | 1,768 | 1,727 | 1,699 | 1,538 | 1,405 | Upgrade
|
| Gross Profit | 2,404 | 2,611 | 3,615 | 2,818 | 2,898 | 3,618 | Upgrade
|
| Selling, General & Admin | 993.77 | 1,066 | 1,465 | 1,205 | 1,011 | 1,328 | Upgrade
|
| Research & Development | 355.91 | 333.18 | 280.84 | 314.7 | 253.63 | 213.21 | Upgrade
|
| Other Operating Expenses | 67.21 | 38.35 | 44.62 | 41.75 | 36.17 | 37.29 | Upgrade
|
| Operating Expenses | 1,431 | 1,432 | 1,805 | 1,595 | 1,312 | 1,621 | Upgrade
|
| Operating Income | 972.53 | 1,179 | 1,810 | 1,223 | 1,586 | 1,997 | Upgrade
|
| Interest Expense | -7.96 | -12.95 | -13.17 | -30.27 | -21.72 | -4.97 | Upgrade
|
| Interest & Investment Income | 126.42 | 157.95 | 164.47 | 128.92 | 85.28 | 100.8 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.15 | -0.15 | -0.3 | -0.01 | 0.33 | 0.3 | Upgrade
|
| Other Non Operating Income (Expenses) | -12.85 | -0.49 | -0.28 | -0.38 | -0.34 | -0.44 | Upgrade
|
| EBT Excluding Unusual Items | 1,078 | 1,323 | 1,961 | 1,322 | 1,650 | 2,093 | Upgrade
|
| Gain (Loss) on Sale of Investments | 26.65 | 32.94 | 60.54 | 36.11 | 26.86 | 25.96 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.52 | 0.08 | 44.44 | 47.67 | 0.42 | -0.26 | Upgrade
|
| Asset Writedown | 6.57 | -5.71 | -9.71 | -1.19 | -3.23 | -0.62 | Upgrade
|
| Other Unusual Items | 0.52 | -11.81 | 21.24 | 24.17 | 14.39 | 29.33 | Upgrade
|
| Pretax Income | 1,112 | 1,339 | 2,078 | 1,428 | 1,688 | 2,147 | Upgrade
|
| Income Tax Expense | 140.25 | 183.14 | 315.96 | 180.76 | 234.13 | 303.21 | Upgrade
|
| Earnings From Continuing Operations | 972.01 | 1,155 | 1,762 | 1,248 | 1,454 | 1,844 | Upgrade
|
| Minority Interest in Earnings | -23.39 | -67.62 | -280.11 | -171.34 | -155.22 | -231.06 | Upgrade
|
| Net Income | 948.62 | 1,088 | 1,482 | 1,076 | 1,299 | 1,613 | Upgrade
|
| Net Income to Common | 948.62 | 1,088 | 1,482 | 1,076 | 1,299 | 1,613 | Upgrade
|
| Net Income Growth | -29.10% | -26.57% | 37.66% | -17.14% | -19.48% | 25.69% | Upgrade
|
| Shares Outstanding (Basic) | 1,827 | 1,826 | 1,824 | 1,825 | 1,821 | 1,818 | Upgrade
|
| Shares Outstanding (Diluted) | 1,827 | 1,829 | 1,824 | 1,828 | 1,831 | 1,820 | Upgrade
|
| Shares Change (YoY) | -0.16% | 0.23% | -0.19% | -0.17% | 0.59% | 0.13% | Upgrade
|
| EPS (Basic) | 0.52 | 0.60 | 0.81 | 0.59 | 0.71 | 0.89 | Upgrade
|
| EPS (Diluted) | 0.52 | 0.59 | 0.81 | 0.59 | 0.71 | 0.89 | Upgrade
|
| EPS Growth | -28.98% | -26.75% | 37.92% | -17.00% | -19.95% | 25.52% | Upgrade
|
| Free Cash Flow | 1,104 | 803.92 | 592.43 | 563.36 | 621.15 | 703.85 | Upgrade
|
| Free Cash Flow Per Share | 0.60 | 0.44 | 0.33 | 0.31 | 0.34 | 0.39 | Upgrade
|
| Dividend Per Share | 0.700 | 0.200 | 0.300 | 0.300 | 0.200 | 0.300 | Upgrade
|
| Dividend Growth | 133.33% | -33.33% | - | 50.00% | -33.33% | -2.50% | Upgrade
|
| Gross Margin | 56.33% | 59.62% | 67.67% | 62.38% | 65.33% | 72.03% | Upgrade
|
| Operating Margin | 22.79% | 26.92% | 33.89% | 27.08% | 35.76% | 39.76% | Upgrade
|
| Profit Margin | 22.23% | 24.84% | 27.73% | 23.83% | 29.28% | 32.11% | Upgrade
|
| Free Cash Flow Margin | 25.87% | 18.36% | 11.09% | 12.47% | 14.00% | 14.01% | Upgrade
|
| EBITDA | 1,233 | 1,439 | 2,069 | 1,496 | 1,783 | 2,179 | Upgrade
|
| EBITDA Margin | 28.90% | 32.86% | 38.74% | 33.12% | 40.18% | 43.38% | Upgrade
|
| D&A For EBITDA | 260.84 | 260.07 | 259.05 | 272.5 | 196.39 | 181.66 | Upgrade
|
| EBIT | 972.53 | 1,179 | 1,810 | 1,223 | 1,586 | 1,997 | Upgrade
|
| EBIT Margin | 22.79% | 26.92% | 33.89% | 27.08% | 35.76% | 39.76% | Upgrade
|
| Effective Tax Rate | 12.61% | 13.68% | 15.21% | 12.65% | 13.87% | 14.12% | Upgrade
|
| Revenue as Reported | 4,267 | 4,379 | 5,342 | 4,517 | 4,436 | 5,023 | Upgrade
|
| Advertising Expenses | - | 5.08 | 6.31 | 2.84 | 3.38 | 2.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.